Besides transcriptional regulation by transcription factors (e.g., Myc, p53), the mechanisms involved in lncRNA aberrant expression in cancer include copy number alterations, mutations, epigenetic changes at lncRNA loci, RNA-processing abnormalities, Epstein–Barr virus infection, etc. [15,73]. This evidence concerns the gene TP53 and cancer.